REGENERATIVE STRATEGIES FOR KIDNEY ENGINEERING

The kidney is the most important organ for water homeostasis and waste excretion. It performs several important physiological functions for homeostasis: it filters the metabolic waste out of circulation, regulates body fluid balances, and acts as an immune regulator and modulator of cardiovascular physiology. The development of in vitro renal disease models with pluripotent stem cells (both human embryonic stem cells and induced pluripotent stem cells) and the generation of robust protocols for in vitro derivation of renal-specific-like cells from patient induced pluripotent stem cells have just emerged. Here we review major findings in the field of kidney regeneration with a major focus on the development of stepwise protocols for kidney cell production from human pluripotent stem cells and the latest advances in kidney bioengineering (i.e. decellularized kidney scaffolds and bioprinting). The possibility of generating renal-like three-dimensional structures to be recellularized with renal-derived induced pluripotent stem cells may offer new avenues to develop functional kidney grafts on-demand.

1. https://www.kidney.org/news/newsroom/factsheets/Organ-Donation-and-Transplantation-Stats.

2. http://optn.transplant.hrsa.gov/3. Song B, Smink AM, Jones CV, et al. The directed differentiation of human iPS cell into kidney podocytes. PLoS One 2012; 7, e46453

3. Narayanan K, Schumacher KM, Tasnim F et al. Human embryonic stem cells differentiate into functional renal proximal tubular-like cells. Kidney 2013; Int 83, 593–603

4. Кatari R, Peloso A, Zambon JP et al. Renal bioengineering with scaffolds generated from human kidneys. Nephron 2014; Exp Nephrol 126, 119–124

5. Mandrycky C, Wang Z, Kim K & Kim DH. 3D bioprinting for engineering complex tissues. Biotechnol 2015; Adv doi: 10.1016/j. biotechadv.2015.12.011

6. Montserrat N, Ramırez-Bajo MJ, Xia Y et al. Generation of induced pluripotent stem cells from human renal proximal tubular cells with only two transcription factors, OCT4 and SOX2. J Biol Chem 2012; 287, 24131–24138

7. Baer PC, Geiger H. Human renal cells from the thick ascending limb and early distal tubule: characterization of primary isolated and cultured cells by reverse transcription polymerase chain reaction. Nephrology 2008; 13, 316–321

8. Baer PC, Nockher WA, Haase W, Scherberich JE. Isolation of proximal and distal tubule cells from human kidney by immunomagnetic separation. Technical note. Kidney 1997; Int 52, 1321–1331

9. Humphreys BD, Czerniak S, DiRocco DP, et al. Repair of injured proximal tubule does not involve specialized progenitors. Proc Natl Acad Sci USA 2011; 108, 9226-9231

10. Song J, Czerniak S, Wang T et al. Characterization and fate of telomerase-expressing epithelia during kidney repair. J Am Soc Nephrol 2011; 22, 2256–2265

11. Humphreys BD, Valerius MT, Kobayashi A et al. Intrinsic epithelial cells repair the kidney after injury. Cell Stem Cell 2008; 2, 284–291

12. Romagnani P, Lasagni L, Remuzzi G. Renal progenitors: an evolutionary conserved strategy for kidney regeneration. Nat Rev Nephrol 2013; 9, 137–146

13. Romagnani P, Anders H-J. What can tubular progenitor cultures teach us about kidney regeneration? Kidney 2013; Int 83, 351–353

14. Osafune K, Takasato M, Kispert A, Asashima MNR. Identification of multipotent progenitors in the embryonic mouse kidney by a novel colonyforming assay. Development 2006; 133, 151–161

15. Little MH, McMahon AP. Mammalian kidney development: principles, progress, and projections.Cold Spring Harb Perspect Biol 2012; 4, 3

16. Thomson JA. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282, 1145–1147

17. Wakayama T, Tabar V, Rodriguez I et al. Differentiation of embryonic stem cell lines generated from adult somatic cells by nuclear transfer. Science 2001; 292, 740–743

18. Tada M, Takahama Y, Abe K et al. Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Curr Biol 2001; 11, 1553–1558

19. Hou P, Li Y, Zhang X et al. Pluripotent stem cells induced from mouse somatic cells by smallmolecule compounds. Science 2013; 341, 651–654

20. Takahashi K, Tanabe K, Ohnuki M et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131, 861–872

21. Kazutoshi Takahashi SY. A developmental framework for induced pluripotency. Development 2015; 142,3274–3285

22. .Zhu S, Li W, Zhou H, Wei et al. Reprogramming of human primary somatic cells by OCT4 and chemical compounds. Cell Stem Cell 2010; 7, 651–655

23. Aasen T, Raya A, Barrero MJ et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol 2008; 26, 1276–1284

24. Giorgetti A, Montserrat N, Aasen T et al. Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2. Cell Stem Cell 2009; 5, 353–357

25. Kim JB, Greber B, Ara et al. Direct reprogramming of human neural stem cells by OCT4. Nature 2009; 461, 649–643

26. Gonzalez F, Boue S, Belmonte JCI. Methods for making induced pluripotent stem cells: reprogramming a la carte. Nat Rev Genet 2011; 12, 231–242

27. Zhou H, Wu S, Joo JY et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 2009; 4, 381–384

28. Kim D, Kim C-H, Moon J-I et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 2009; 4, 472–476

29. Okita K, Matsumura Y, Sato Y et al. A more efficient method to generate integration-free human iPS cells. Nat Methods 2011; 8, 409–412

30. Warren L, Manos PD, Ahfeldt T et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 2010; 7, 618–630

31. Anokye-Danso F, Trivedi CM, Juhr D et al. Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell 2011; 8, 376–388

32. Meng G, Liu S, Rancourt DE. Synergistic effect of medium, matrix, and exogenous factors on the adhesion and growth of human pluripotent stem cells under defined, xeno-free conditions. Stem Cells Dev 2012; 21, 2036–2048

33. Sugii S, Kida Y, Kawamura T et al. Human and mouse adiposederived cells support feeder-independent induction of pluripotent stem cells. Proc Natl Acad Sci USA 2010; 107, 3558–3563.

34. Nakagawa M, Taniguchi Y, Senda S et al. A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells. Sci Rep 2014; 4, 3594

35. Raya A, Rodrıguez-Piza I, Guenechea G et al. Diseasecorrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature 2009; 460, 53–59

36. Ebert AD, Yu J, Rose FF et al. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 2009; 457, 277–280

37. Ye L, Chang JC, Lin C et al. Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases. Proc Natl Acad Sci USA 2009; 106, 9826–9830

38. Liu G-H, Barkho BZ, Ruiz S et al. Recapitulation of premature aging with iPSCs from Hutchinson-Gilford progeria syndrome. Nature 2009; 472, 221–225

39. Itzhaki I, Maizels L, Huber I et al. Modelling the long QT syndrome with induced pluripotent stem cells. Nature 2011; 471, 225–229

40. Nguyen HN, Byers B, Cord B et al. LRRK2 mutant iPSCderived DA neurons demonstrate increased susceptibility to oxidative stress. Cell Stem Cell 2011; 8, 267–280

41. Lee G, Papapetrou EP, Kim H et al. Modeling pathogenesis and treatment of familial dysautonomia using patient specific iPSCs. Nature 2011; 461, 402–406

42. Moretti A, Bellin M, Welling A et al. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N Engl J Med 2010; 363, 1397–1409

43. Li M, Suzuki K, Kim NY et al. A cut above the rest: targeted genome editing technologies in human pluripotent stem cells. J Biol Chem 2014; 289, 4594–4599

44. Liu G-H, Suzuki K, Qu J et al. Targeted gene correction of laminopathyassociated LMNA mutations in patient-specific iPSCs. Cell Stem Cell 2011; 8, 688–694

45. Howden SE, Gore A, Li Z et al. Genetic correction and analysis of induced pluripotent stem cells from a patient with gyrate atrophy. Proc Natl Acad Sci USA 2011; 108, 6537–6542

46. Papapetrou EP, Lee G, Malani N et al. Genomic safe harbors permit high b-globin transgene expression in thalassemia induced pluripotent stem cells. Nat Biotechnol 2011; 29,73–78

47. Li M, Suzuki K, Qu J et al. Efficient correction of hemoglobinopathycausing mutations by homologous recombination in integration-free patient iPSCs. Cell Res 2011; 21, 1740–1744

48. Liu G-H, Qu J, Suzuki K et al. Progressive degeneration of human neural stem cells caused by pathogenic LRRK2. Nature 2012; 491, 603–607

49. Fattahi F, Steinbeck JA, Kriks S et al. Deriving human ENS lineages for cell therapy and drug discovery in Hirschsprung disease. Nature 2016; 531, 105–109

50. Tiscornia G, Vivas EL, Izpisua Belmonte JC. Diseases in a dish: modeling human genetic disorders using induced pluripotent cells. Nat Med 2011; 17, 1570–1576

51. Shankland SJ, Pippin JW, Reiser J, Mundel P. Podocytes in culture: past, present, and future. Kidney Int 2007; 72, 26–36

52. Mae S-I, Shono A, Shiota F et al. Monitoring and robust induction of nephrogenic intermediate mesoderm from human pluripotent stem cells. Nat Commun 2013; 4, 1367

53. Araoka T, Mae S, Kurose Y et al. Efficient and rapid induction of human iPSCs/ESCs into nephrogenic intermediate mesoderm using small molecule-based differentiation methods. PLoS One 2014; 9, e84881

54. Xia Y, Nivet E, Sancho-Martinez I et al. Directed differentiation of human pluripotent cells to ureteric bud kidney progenitorlike cells. Nat Cell Biol 2013; 15, 1507–1515

55. Takasato M, Er PX, Becroft M et al. Directing human embryonic stem cell differentiation towards a renal lineage generates a self-organizing kidney. Nat Cell Biol 2014; 16, 118–126

56. Lam AQ, Freedman BS, Morizane R et al. Rapid and efficient differentiation of human pluripotent stem cells into intermediate mesoderm that forms tubules expressing kidney proximal tubular markers. J Am Soc Nephrol 2013; 25, 1211–1225

57. Taguchi A, Kaku Y, Ohmori T et al. Redefining the in vivo origin of metanephric nephron progenitors enables generation of complex kidney structures from pluripotent stem cells. Cell Stem Cell 2014; 14, 53–67

58. Imberti B, Tomasoni S, Ciampi O et al. Renal progenitors derived from human iPSCs engraft and restore function in a mouse model of acute kidney injury. Sci Rep 2015; 5, 8826

59. Morizane R, Lam AQ, Freedman BS et al. Nephron organoids derived from human pluripotent stem cells model kidney development and injury. Nat Biotechnol 2015; 33, 1193–1200

60. Freedman BS, Brooks CR, Lam AQ et al. Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids. Nat Commun 2015; 6, 8715

61. Takasato M, Er PX, Chiu HS et al. Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis. Nature 2015; 526, 564–568

62. Xiao-Jie L, Hui-Ying X, Zun-Ping K et al. CRISPR-Cas9: a new and promising player in gene therapy. J Med Genet 2015; 52, 289–296

63. Hu J, Lei Y, Wong W-K, Liu S et al. Direct activation of human and mouse Oct4 genes using engineered TALE and Cas9 transcription factors. Nucleic Acids Res 2014; 42, 4375–4390

64. Elliott DA, Braam SR, Koutsis K et al. NKX2-5eGFP/w hESCs for isolation of human cardiac progenitors and cardiomyocytes. Nat Methods 2011; 8, 1037–1040

65. Den Hartogh SC, Schreurs C, Monshouwer-Kloots JJ et al. Dual reporter MESP1 mCherry/w -NKX2-5 eGFP/w hESCs enable studying early human cardiac differentiation. Stem Cells 2015; 33, 56–67

66. Krentz NA, Nian CLF. TALEN/CRISPRmediated eGFP knock-in add-on at the OCT4 locus does not impact differentiation of human embryonic stem cells towards endoderm. PLoS One 2014; 9, e114275

67. Langer R, Vacanti JP. Tissue engineering. Science 1993; 260, 920–926 69. Kim TG, Shin H, Lim DW. Biomimetic scaffolds for tissue engineering. Adv Funct Mater 2012; 22, 2446–2468

68. Mallick KK, Cox SC. Biomaterial scaffolds for tissue engineering. Front Biosci 2013; 5, 341–360

69. Kamel RA, Ong JF, Eriksson E et al. Tissue engineering of skin. J Am Coll Surg 2013; 217: 533–555

70. Sittinger M, Bujia J, Minuth WW et al. Engineering of cartilage tissue using bioresorbable polymer carriers in perfusion culture. Biomaterials 1994; 15, 451–456

71. Liao J, Guo X, Grande-Allen KJ et al. Bioactive polymer/ extracellular matrix scaffolds fabricated with a flow perfusion bioreactor for cartilage tissue engineering. Biomaterials 2010; 31, 8911–8920

72. Amini AR, Laurencin CT, Nukavarapu SP. Bone tissue engineering: recent advances and challenges. Crit Rev Biomed Eng 2012; 40, 363–408

73. Atala A. Tissue engineering of human bladder. Br Med Bull 2011; 97, 81–104

74. Koike N, Fukumura D, Gralla O et al. Tissue engineering: creation of longlasting blood vessels. Nature 2004; 428, 138–139

75. Kojima K, Vacanti CA.Tissue engineering in the trachea. Anat Rec 2014; 297, 44–50

76. Tapias LF, Ott HC. Decellularized scaffolds as a platform for bioengineered organs. Curr Opin Organ Transplant 2014; 19, 145–152

77. Ross EA, Williams MJ, Hamazaki T et al. Embryonic stem cells proliferate and differentiate when seeded into kidney scaffolds. J Am Soc Nephrol 2014; 20, 2338–2347

78. Song JJ, Guyette JP, Gilpin SE et al. Regeneration and experimental orthotopic transplantation of a bioengineered kidney. Nat Med 2013; 19, 646–651

79. Burgkart R, Tron A, Prodinger P et al. Decellularized kidney matrix for perfused bone engineering. Tissue Eng Part C Methods 2014; 20, 553–561

80. Bonandrini B, Figliuzzi M, Papadimou E et al. Recellularization of wellpreserved acellular kidney scaffold using embryonic stem cells. Tissue Eng Part A 2014; 20, 1486–1498

81. Caralt M, Uzarski JS, Iacob S et al. Optimization and critical evaluation of decellularization strategies to develop renal extracellular matrix scaffolds as biological templates for organ engineering and transplantation. Am J Transplant 2014; 15, 64–75

82. Peloso A, Ferrario J, Maiga B et al. Creation and implantation of acellular rat renal ECM-based scaffolds. Organogenesis 2015; 1, 58–74

83. Guan Y, Liu S, Sun C et al. The effective bioengineering method of implantation decellularized renal extracellular matrix scaffolds. Oncotarget 2015; 6, 36126–36138

84. Sullivan DC, Mirmalek-Sani SH, Deegan DB et al. Decellularization methods of porcine kidneys for whole organ engineering using a high-throughput system. Biomaterials 2012; 33, 7756–7764

85. Orlando G, Farney AC, Iskandar SS et al. Production and implantation of renal extracellular matrix scaffolds from porcine kidneys as a platform for renal bioengineering investigations. Ann Surg 2012; 256, 363–370

86. Guan Y, Liu S, Liu Y et al. Porcine kidneys as a source of ECM scaffold for kidney regeneration. Mater Sci Eng C Mater Biol Appl 2015; 56, 451–456

87. Nakayama KH, Batchelder CA, Lee CI, Tarantal AF. Decellularized rhesus monkey kidney as a three-dimensional scaffold for renal tissue engineering. Tissue Eng Part A 2010; 16, 2207–2216

88. Orlando G, Booth C, Wang Z et al. Discarded human kidneys as a source of ECM scaffold for kidney regeneration technologies. Biomaterials 2013; 34, 5915–5925

89. Peloso A, Petrosyan A, Da Sacco S et al. Renal extracellular matrix scaffolds from discarded kidneys maintain glomerular morphometry and vascular resilience and retains critical growth factors. Transplantation 2015; 99, 1807–1816

90. Crapo PM, Gilbert TW, Badylak SF. An overview of tissue and whole organ decellularization processes. Biomaterials 2012; 32, 3233–3243

91. He M, Callanan A. Comparison of methods for whole-organ decellularization in tissue engineering of bioartificial organs. Tissue Eng Part B Rev 2013; 19, 194–208

92. Keane TJ, Swinehart I, Badylak SF. Methods of tissue decellularization used for preparation of biologic scaffolds and in-vivo relevance. Methods 2015; 84, 25–34

93. Nakayama KH, Lee CCI, Batchelder CA, Tarantal AF. Tissue specificity of decellularized rhesus monkey kidney and lung scaffolds. PLoS One 2013; 8, e64134

94. O’Neill JD, Freytes DO, Anandappa AJ et al. The regulation of growth and metabolism of kidney stem cells with regional specificity using extracellular matrix derived from kidney. Biomaterials 2013; 34, 9830–9841

95. Yu YL, Shao YK, Ding YQ et al. Decellularized kidney scaffold-mediated renal regeneration. Biomaterials 2014; 35, 6822–6828

96. Abolbashari M, Agcaoili SM, Lee MK et al. Repopulation of porcine kidney scaffold using porcine primary renal cells. Acta Biomater 2016; 29, 52–61

97. Ross EA, Abrahamson DR, St. John P et al. Mouse stem cells seeded into decellularized rat kidney scaffolds endothelialize and remodel basement membranes. Organogenesis 2012; 8, 49–55

98. Bijonowski BM, Miller WM, Wertheim JA. Bioreactor design for perfusion-based, highly vascularized organ regeneration. Curr Opin Chem Eng 2013; 2, 32–40

99. Pollock CA. Toward a bioartificial kidney: will embryonic stem cells be the answer? Kidney 2013; Int 83, 543–545

100. Badylak SF, Taylor D, Uygun K. Wholeorgan tissue engineering: decellularization and recellularization of three-dimensional matrix scaffolds. Annu Rev Biomed Eng 2011; 13, 27–53

101. Murphy SV, Atala A. 3D bioprinting of tissues and organs. Nat Biotechnol 2014; 32, 773–785

102. Groll J, Boland T, Blunk T et al. Biofabrication: reappraising the definition of an evolving field. Biofabrication 2016; 8, 013001

103. Skardal A, Atala A. Biomaterials for integration with 3-D bioprinting. Ann Biomed Eng 2015; 43, 730–746

104. Chung JHY, Naficy S, Yue Z et al. Bio-ink properties and printability for extrusion printing living cells. Biomater Sci 2013; 1, 763

105. Ferris CJ, Gilmore KJ, Beirne S et al. Bio-ink for ondemand printing of living cells. Biomater Sci 2013; 1, 224

106. Pati F, Jang J, Ha D-H, et al. Printing threedimensional tissue analogues with decellularized extracellular matrix bioink. Nat Commun 2014; 5, 3935

107. Fullhase C, Soler R, Atala A et al. A novel hybrid printing system for the generation of organized bladder tissue. J Urol 2009; 181, 282–283

108. Williams SK, Touroo JS, Church KH, Hoying JB. Encapsulation of adipose stromal vascular fraction cells in alginate hydrogel spheroids using a direct-write three-dimensional printing system. Biores Open Access 2013; 2, 448–454

109. Mironov V, Visconti RP, Kasyanov V et al. Organ printing: tissue spheroids as building blocks. Biomaterials 2009; 30, 2164–2174

110. Faulkner-Jones A, Greenhough S, King JA et al. Development of a valve-based cell printer for the formation of human embryonic stem cell spheroid aggregates. Biofabrication 2013; 5, 015013

111. Faulkner-Jones A, Fyfe C, Cornelissen DJ, Gardner et al. Bioprinting of human pluripotent stem cells and their directed differentiation into hepatocyte-like cells for the generation of minilivers in 3D. Biofabrication 2015; 7, 044102